BENZYLDIMETHYL(2-PHENOXYETHYL)AMMONIUM IODIDE

US Previously Marketed

First approved in 1967

Details

Stereochemistry	ACHIRAL
Molecular Formula	C17H22NO.I
Molecular Weight	383.2672
Optical Activity	NONE
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BENZYLDIMETHYL(2-PHENOXYETHYL)AMMONIUM IODIDE

Structure Search

SMILES

[I-].C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2

InChI

InChIKey=DIOXOSVQQBOCNQ-UHFFFAOYSA-M

InChI=1S/C17H22NO.HI/c1-18(2,15-16-9-5-3-6-10-16)13-14-19-17-11-7-4-8-12-17;/h3-12H,13-15H2,1-2H3;1H/q+1;/p-1

HIDE SMILES / InChI

Description
Sources: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540057/all/Bephenium_hydroxynaphthoate | https://www.ncbi.nlm.nih.gov/pubmed/14406934 | https://www.ncbi.nlm.nih.gov/pubmed/22526556

BEPHENIUM HYDROXYNAPHTHOATE is an anthelmintic agent used in the treatment of hookworm and roundworm infections (Ancylostoma duodenale, Ascaris lumbricoides, and Necatore americanus). It targets the AChRs of nematodes producing spastic paralysis of the worms.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
B-type AChR, nematode 2 Target ID: B-type AChR, nematode Sources: https://www.ncbi.nlm.nih.gov/pubmed/22526556	Agonist 2752
Ascaris suum 2 Target ID: CHEMBL613136 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14406934	Inhibitor 8504

PubMed

Title	Date	PubMed
Selective effect of the anthelmintic bephenium on Haemonchus contortus levamisole-sensitive acetylcholine receptors.	2012-06	22526556
Pyrantel Embonate And Bephenium Hydroxynaphthoate In The Treatment Of Hookworm Infection.	1975-06	12913463
Bephenium hydroxynaphthoate in treatment of ascariasis.	1960-07-23	14406934

Patents

Name

Type

Language

BENZYLDIMETHYL(2-PHENOXYETHYL)AMMONIUM IODIDE

Systematic Name

English

NSC-131401

Preferred Name

English

Benzenemethanaminium, N,N-dimethyl-N-(2-phenoxyethyl)-, iodide (1:1)

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID80935826